Hiroyasu Sakai

8PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersNanotoxicology, health and safetyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 15, 2026
Subcutaneous Adipose Tissue Accumulation is Associated With an Improved Prognosis in Patients With Hepatocellular Carcinoma.

Kenji Imai, Koji Takai, Mikita Oi

|Mar 21, 2026
Suppression of Indoleamine 2,3-Dioxygenase Enhances Immune Responses to the Therapeutic Vaccine for Chronic Hepatitis B.

Yohei Shirakami, Soranobu Ninomiya, Takayasu Ideta

|Jul 29, 2025
Excessive Visceral Adipose Tissue Accumulation Increases the Risk of Recurrence and Mortality After Curative Treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatocellular Carcinoma.

Kenji Imai, Koji Takai, Mikita Oi

|Feb 13, 2025
Dual Roles of Canagliflozin on Cholangiocarcinoma Cell Growth and Enhanced Growth Suppression in Combination with FK866.

Daisuke Taguchi, Yohei Shirakami, Hiroyasu Sakai

|Jan 25, 2025
Psoas Muscle Index as an Independent Predictor of Survival in Patients with Hepatocellular Carcinoma Receiving Systemic Targeted Therapy.

Kenji Imai, Koji Takai, Masashi Aiba

|Nov 09, 2024
Glyburide Suppresses Inflammation-Related Colorectal Tumorigenesis Through Inhibition of NLRP3 Inflammasome.

Toshihide Maeda, Yohei Shirakami, Daisuke Taguchi

Pageof 2

Frequent Collaborators

7 joint publications

Yohei Shirakami

6 joint publications

Takao Miwa

4 joint publications

Shinji Unome

4 joint publications

Kenji Imai